David Solomon was under siege from partners critical of his leadership. The firm launched a probe to identify leakers.

Goldman Sachs' Denis Coleman and Morgan Stanley's Lauren Belmonte on how sweating the small stuff can boost your career.

Goldman Sachs forecasts strong growth for diabetes tech, backing Dexcom and Insulet while rating Tandem and Beta Bionics as ...

Goldman Sachs analyst David Roman initiated coverage with a Buy rating on Dexcom (DXCM – Research Report) today and set a price target of $104.00. The company’s shares closed ...

Goldman Sachs initiated coverage of DexCom (DXCM) stock with a Buy rating and a price target of $104 as part of a broader research note commencing coverage on Diabetes Medical Technology. Goldman ...

DexCom, a global leader in glucose biosensing systems, stands out for its innovative continuous glucose monitoring (CGM) ...

Shares of Beta Bionics rose Thursday following the initiation of coverage by two Wall Street financial firms on the ...

In this article, we are going to take a look at where The Goldman Sachs Group, Inc. (NYSE:GS) stands against other stocks that Jim Cramer discussed recently. On Monday, Mad Money host Jim Cramer ...

Goldman Sachs continues to believe oil prices will weaken in the second half of the year as a possible U.S.-Iran nuclear deal and higher global stocks offset an improving global economic outlook ...

The artificial intelligence rally over the past two and a half years, led by the so-called Magnificent 7, was remarkable if you owned those stocks. Those heady days, at least for now, are over.

At this year's WrestleMania, Roman Reigns was betrayed by Paul Heyman (as was CM Punk) when the Wiseman allied himself with Seth Rollins. The next night on RAW, the OTC attempted to exact revenge but ...

The Goldman Sachs Conviction List contains the top stock picks at one of Wall Street’s top firms. Are the dividend stocks in the Conviction List a good idea for you? Why not schedule a meeting ...